img

Global Specialty Biopharmaceutical Excipients Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 112 | Industry : Medical Care

Publisher : q | Format : PDF

Global Specialty Biopharmaceutical Excipients Market Research Report 2024

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
膨胀剂
溶解度增强剂
表面活性剂
其他


Segment by Application


Oral Medication
Injection Medicine
Other

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE




By Company


Merck KGaA
Signet Excipients Pvt. Ltd
Sigachi Industries Limited
Associated British Foods plc
Spectrum Chemical Manufacturing Corp.
Roquette Freres
IMCD
Clariant
DFE Pharma
Colorcon
BASF
Evonik Industries
J. RETTENMAIER & SOHNE GmbH

Table of Content

1 Specialty Biopharmaceutical Excipients Market Overview
1.1 Product Overview and Scope of Specialty Biopharmaceutical Excipients
1.2 Specialty Biopharmaceutical Excipients Segment by Type
1.2.1 Global Specialty Biopharmaceutical Excipients Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 膨胀剂
1.2.3 溶解度增强剂
1.2.4 表面活性剂
1.2.5 其他
1.3 Specialty Biopharmaceutical Excipients Segment by Application
1.3.1 Global Specialty Biopharmaceutical Excipients Sales Comparison by Application: (2021-2027)
1.3.2 Oral Medication
1.3.3 Injection Medicine
1.3.4 Other
1.4 Global Specialty Biopharmaceutical Excipients Market Size Estimates and Forecasts
1.4.1 Global Specialty Biopharmaceutical Excipients Revenue 2016-2027
1.4.2 Global Specialty Biopharmaceutical Excipients Sales 2016-2027
1.4.3 Specialty Biopharmaceutical Excipients Market Size by Region: 2016 Versus 2021 Versus 2027

2 Specialty Biopharmaceutical Excipients Market Competition by Manufacturers
2.1 Global Specialty Biopharmaceutical Excipients Sales Market Share by Manufacturers (2016-2021)
2.2 Global Specialty Biopharmaceutical Excipients Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Specialty Biopharmaceutical Excipients Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Specialty Biopharmaceutical Excipients Manufacturing Sites, Area Served, Product Type
2.5 Specialty Biopharmaceutical Excipients Market Competitive Situation and Trends
2.5.1 Specialty Biopharmaceutical Excipients Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Specialty Biopharmaceutical Excipients Players Market Share by Revenue
2.5.3 Global Specialty Biopharmaceutical Excipients Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Specialty Biopharmaceutical Excipients Retrospective Market Scenario by Region
3.1 Global Specialty Biopharmaceutical Excipients Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Specialty Biopharmaceutical Excipients Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Specialty Biopharmaceutical Excipients Market Facts & Figures by Country
3.3.1 North America Specialty Biopharmaceutical Excipients Sales by Country
3.3.2 North America Specialty Biopharmaceutical Excipients Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Specialty Biopharmaceutical Excipients Market Facts & Figures by Country
3.4.1 Europe Specialty Biopharmaceutical Excipients Sales by Country
3.4.2 Europe Specialty Biopharmaceutical Excipients Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Specialty Biopharmaceutical Excipients Market Facts & Figures by Region
3.5.1 Asia Pacific Specialty Biopharmaceutical Excipients Sales by Region
3.5.2 Asia Pacific Specialty Biopharmaceutical Excipients Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Specialty Biopharmaceutical Excipients Market Facts & Figures by Country
3.6.1 Latin America Specialty Biopharmaceutical Excipients Sales by Country
3.6.2 Latin America Specialty Biopharmaceutical Excipients Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Specialty Biopharmaceutical Excipients Market Facts & Figures by Country
3.7.1 Middle East and Africa Specialty Biopharmaceutical Excipients Sales by Country
3.7.2 Middle East and Africa Specialty Biopharmaceutical Excipients Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Specialty Biopharmaceutical Excipients Historic Market Analysis by Type
4.1 Global Specialty Biopharmaceutical Excipients Sales Market Share by Type (2016-2021)
4.2 Global Specialty Biopharmaceutical Excipients Revenue Market Share by Type (2016-2021)
4.3 Global Specialty Biopharmaceutical Excipients Price by Type (2016-2021)

5 Global Specialty Biopharmaceutical Excipients Historic Market Analysis by Application
5.1 Global Specialty Biopharmaceutical Excipients Sales Market Share by Application (2016-2021)
5.2 Global Specialty Biopharmaceutical Excipients Revenue Market Share by Application (2016-2021)
5.3 Global Specialty Biopharmaceutical Excipients Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Merck KGaA
6.1.1 Merck KGaA Corporation Information
6.1.2 Merck KGaA Description and Business Overview
6.1.3 Merck KGaA Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Merck KGaA Specialty Biopharmaceutical Excipients Product Portfolio
6.1.5 Merck KGaA Recent Developments/Updates
6.2 Signet Excipients Pvt. Ltd
6.2.1 Signet Excipients Pvt. Ltd Corporation Information
6.2.2 Signet Excipients Pvt. Ltd Description and Business Overview
6.2.3 Signet Excipients Pvt. Ltd Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Signet Excipients Pvt. Ltd Specialty Biopharmaceutical Excipients Product Portfolio
6.2.5 Signet Excipients Pvt. Ltd Recent Developments/Updates
6.3 Sigachi Industries Limited
6.3.1 Sigachi Industries Limited Corporation Information
6.3.2 Sigachi Industries Limited Description and Business Overview
6.3.3 Sigachi Industries Limited Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Sigachi Industries Limited Specialty Biopharmaceutical Excipients Product Portfolio
6.3.5 Sigachi Industries Limited Recent Developments/Updates
6.4 Associated British Foods plc
6.4.1 Associated British Foods plc Corporation Information
6.4.2 Associated British Foods plc Description and Business Overview
6.4.3 Associated British Foods plc Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Associated British Foods plc Specialty Biopharmaceutical Excipients Product Portfolio
6.4.5 Associated British Foods plc Recent Developments/Updates
6.5 Spectrum Chemical Manufacturing Corp.
6.5.1 Spectrum Chemical Manufacturing Corp. Corporation Information
6.5.2 Spectrum Chemical Manufacturing Corp. Description and Business Overview
6.5.3 Spectrum Chemical Manufacturing Corp. Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Spectrum Chemical Manufacturing Corp. Specialty Biopharmaceutical Excipients Product Portfolio
6.5.5 Spectrum Chemical Manufacturing Corp. Recent Developments/Updates
6.6 Roquette Freres
6.6.1 Roquette Freres Corporation Information
6.6.2 Roquette Freres Description and Business Overview
6.6.3 Roquette Freres Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Roquette Freres Specialty Biopharmaceutical Excipients Product Portfolio
6.6.5 Roquette Freres Recent Developments/Updates
6.7 IMCD
6.6.1 IMCD Corporation Information
6.6.2 IMCD Description and Business Overview
6.6.3 IMCD Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2016-2021)
6.4.4 IMCD Specialty Biopharmaceutical Excipients Product Portfolio
6.7.5 IMCD Recent Developments/Updates
6.8 Clariant
6.8.1 Clariant Corporation Information
6.8.2 Clariant Description and Business Overview
6.8.3 Clariant Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Clariant Specialty Biopharmaceutical Excipients Product Portfolio
6.8.5 Clariant Recent Developments/Updates
6.9 DFE Pharma
6.9.1 DFE Pharma Corporation Information
6.9.2 DFE Pharma Description and Business Overview
6.9.3 DFE Pharma Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2016-2021)
6.9.4 DFE Pharma Specialty Biopharmaceutical Excipients Product Portfolio
6.9.5 DFE Pharma Recent Developments/Updates
6.10 Colorcon
6.10.1 Colorcon Corporation Information
6.10.2 Colorcon Description and Business Overview
6.10.3 Colorcon Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Colorcon Specialty Biopharmaceutical Excipients Product Portfolio
6.10.5 Colorcon Recent Developments/Updates
6.11 BASF
6.11.1 BASF Corporation Information
6.11.2 BASF Specialty Biopharmaceutical Excipients Description and Business Overview
6.11.3 BASF Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2016-2021)
6.11.4 BASF Specialty Biopharmaceutical Excipients Product Portfolio
6.11.5 BASF Recent Developments/Updates
6.12 Evonik Industries
6.12.1 Evonik Industries Corporation Information
6.12.2 Evonik Industries Specialty Biopharmaceutical Excipients Description and Business Overview
6.12.3 Evonik Industries Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Evonik Industries Specialty Biopharmaceutical Excipients Product Portfolio
6.12.5 Evonik Industries Recent Developments/Updates
6.13 J. RETTENMAIER & SOHNE GmbH
6.13.1 J. RETTENMAIER & SOHNE GmbH Corporation Information
6.13.2 J. RETTENMAIER & SOHNE GmbH Specialty Biopharmaceutical Excipients Description and Business Overview
6.13.3 J. RETTENMAIER & SOHNE GmbH Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2016-2021)
6.13.4 J. RETTENMAIER & SOHNE GmbH Specialty Biopharmaceutical Excipients Product Portfolio
6.13.5 J. RETTENMAIER & SOHNE GmbH Recent Developments/Updates

7 Specialty Biopharmaceutical Excipients Manufacturing Cost Analysis
7.1 Specialty Biopharmaceutical Excipients Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Specialty Biopharmaceutical Excipients
7.4 Specialty Biopharmaceutical Excipients Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Specialty Biopharmaceutical Excipients Distributors List
8.3 Specialty Biopharmaceutical Excipients Customers

9 Specialty Biopharmaceutical Excipients Market Dynamics
9.1 Specialty Biopharmaceutical Excipients Industry Trends
9.2 Specialty Biopharmaceutical Excipients Growth Drivers
9.3 Specialty Biopharmaceutical Excipients Market Challenges
9.4 Specialty Biopharmaceutical Excipients Market Restraints

10 Global Market Forecast
10.1 Specialty Biopharmaceutical Excipients Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Specialty Biopharmaceutical Excipients by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Specialty Biopharmaceutical Excipients by Type (2022-2027)
10.2 Specialty Biopharmaceutical Excipients Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Specialty Biopharmaceutical Excipients by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Specialty Biopharmaceutical Excipients by Application (2022-2027)
10.3 Specialty Biopharmaceutical Excipients Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Specialty Biopharmaceutical Excipients by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Specialty Biopharmaceutical Excipients by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Specialty Biopharmaceutical Excipients Sales (Tons) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Specialty Biopharmaceutical Excipients Sales (Tons) Comparison by Application (2021-2027)
Table 3. Global Specialty Biopharmaceutical Excipients Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Specialty Biopharmaceutical Excipients Covered in This Study
Table 5. Global Specialty Biopharmaceutical Excipients Sales (Tons) of Key Manufacturers (2016-2021)
Table 6. Global Specialty Biopharmaceutical Excipients Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Specialty Biopharmaceutical Excipients Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Specialty Biopharmaceutical Excipients Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Specialty Biopharmaceutical Excipients Average Price (US$/Ton) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Specialty Biopharmaceutical Excipients Manufacturing Sites and Area Served
Table 11. Manufacturers Specialty Biopharmaceutical Excipients Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Specialty Biopharmaceutical Excipients by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Specialty Biopharmaceutical Excipients as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Specialty Biopharmaceutical Excipients Sales by Region (2016-2021) & (Tons)
Table 16. Global Specialty Biopharmaceutical Excipients Sales Market Share by Region (2016-2021)
Table 17. Global Specialty Biopharmaceutical Excipients Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Specialty Biopharmaceutical Excipients Sales by Country (2016-2021) & (Tons)
Table 19. North America Specialty Biopharmaceutical Excipients Sales Market Share by Country (2016-2021)
Table 20. North America Specialty Biopharmaceutical Excipients Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Specialty Biopharmaceutical Excipients Revenue Market Share by Country (2016-2021)
Table 22. Europe Specialty Biopharmaceutical Excipients Sales by Country (2016-2021) & (Tons)
Table 23. Europe Specialty Biopharmaceutical Excipients Sales Market Share by Country (2016-2021)
Table 24. Europe Specialty Biopharmaceutical Excipients Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Specialty Biopharmaceutical Excipients Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Specialty Biopharmaceutical Excipients Sales by Region (2016-2021) & (Tons)
Table 27. Asia Pacific Specialty Biopharmaceutical Excipients Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Specialty Biopharmaceutical Excipients Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Specialty Biopharmaceutical Excipients Revenue Market Share by Region (2016-2021)
Table 30. Latin America Specialty Biopharmaceutical Excipients Sales by Country (2016-2021) & (Tons)
Table 31. Latin America Specialty Biopharmaceutical Excipients Sales Market Share by Country (2016-2021)
Table 32. Latin America Specialty Biopharmaceutical Excipients Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Specialty Biopharmaceutical Excipients Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Specialty Biopharmaceutical Excipients Sales by Country (2016-2021) & (Tons)
Table 35. Middle East and Africa Specialty Biopharmaceutical Excipients Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Specialty Biopharmaceutical Excipients Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Specialty Biopharmaceutical Excipients Revenue Market Share by Country (2016-2021)
Table 38. Global Specialty Biopharmaceutical Excipients Sales (Tons) by Type (2016-2021)
Table 39. Global Specialty Biopharmaceutical Excipients Sales Market Share by Type (2016-2021)
Table 40. Global Specialty Biopharmaceutical Excipients Revenue (Million US$) by Type (2016-2021)
Table 41. Global Specialty Biopharmaceutical Excipients Revenue Share by Type (2016-2021)
Table 42. Global Specialty Biopharmaceutical Excipients Price (US$/Ton) by Type (2016-2021)
Table 43. Global Specialty Biopharmaceutical Excipients Sales (Tons) by Application (2016-2021)
Table 44. Global Specialty Biopharmaceutical Excipients Sales Market Share by Application (2016-2021)
Table 45. Global Specialty Biopharmaceutical Excipients Revenue (Million US$) by Application (2016-2021)
Table 46. Global Specialty Biopharmaceutical Excipients Revenue Share by Application (2016-2021)
Table 47. Global Specialty Biopharmaceutical Excipients Price (US$/Ton) by Application (2016-2021)
Table 48. Merck KGaA Corporation Information
Table 49. Merck KGaA Description and Business Overview
Table 50. Merck KGaA Specialty Biopharmaceutical Excipients Sales (Tons), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 51. Merck KGaA Specialty Biopharmaceutical Excipients Product
Table 52. Merck KGaA Recent Developments/Updates
Table 53. Signet Excipients Pvt. Ltd Corporation Information
Table 54. Signet Excipients Pvt. Ltd Description and Business Overview
Table 55. Signet Excipients Pvt. Ltd Specialty Biopharmaceutical Excipients Sales (Tons), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 56. Signet Excipients Pvt. Ltd Specialty Biopharmaceutical Excipients Product
Table 57. Signet Excipients Pvt. Ltd Recent Developments/Updates
Table 58. Sigachi Industries Limited Corporation Information
Table 59. Sigachi Industries Limited Description and Business Overview
Table 60. Sigachi Industries Limited Specialty Biopharmaceutical Excipients Sales (Tons), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 61. Sigachi Industries Limited Specialty Biopharmaceutical Excipients Product
Table 62. Sigachi Industries Limited Recent Developments/Updates
Table 63. Associated British Foods plc Corporation Information
Table 64. Associated British Foods plc Description and Business Overview
Table 65. Associated British Foods plc Specialty Biopharmaceutical Excipients Sales (Tons), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 66. Associated British Foods plc Specialty Biopharmaceutical Excipients Product
Table 67. Associated British Foods plc Recent Developments/Updates
Table 68. Spectrum Chemical Manufacturing Corp. Corporation Information
Table 69. Spectrum Chemical Manufacturing Corp. Description and Business Overview
Table 70. Spectrum Chemical Manufacturing Corp. Specialty Biopharmaceutical Excipients Sales (Tons), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 71. Spectrum Chemical Manufacturing Corp. Specialty Biopharmaceutical Excipients Product
Table 72. Spectrum Chemical Manufacturing Corp. Recent Developments/Updates
Table 73. Roquette Freres Corporation Information
Table 74. Roquette Freres Description and Business Overview
Table 75. Roquette Freres Specialty Biopharmaceutical Excipients Sales (Tons), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 76. Roquette Freres Specialty Biopharmaceutical Excipients Product
Table 77. Roquette Freres Recent Developments/Updates
Table 78. IMCD Corporation Information
Table 79. IMCD Description and Business Overview
Table 80. IMCD Specialty Biopharmaceutical Excipients Sales (Tons), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 81. IMCD Specialty Biopharmaceutical Excipients Product
Table 82. IMCD Recent Developments/Updates
Table 83. Clariant Corporation Information
Table 84. Clariant Description and Business Overview
Table 85. Clariant Specialty Biopharmaceutical Excipients Sales (Tons), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 86. Clariant Specialty Biopharmaceutical Excipients Product
Table 87. Clariant Recent Developments/Updates
Table 88. DFE Pharma Corporation Information
Table 89. DFE Pharma Description and Business Overview
Table 90. DFE Pharma Specialty Biopharmaceutical Excipients Sales (Tons), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 91. DFE Pharma Specialty Biopharmaceutical Excipients Product
Table 92. DFE Pharma Recent Developments/Updates
Table 93. Colorcon Corporation Information
Table 94. Colorcon Description and Business Overview
Table 95. Colorcon Specialty Biopharmaceutical Excipients Sales (Tons), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 96. Colorcon Specialty Biopharmaceutical Excipients Product
Table 97. Colorcon Recent Developments/Updates
Table 98. BASF Corporation Information
Table 99. BASF Description and Business Overview
Table 100. BASF Specialty Biopharmaceutical Excipients Sales (Tons), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 101. BASF Specialty Biopharmaceutical Excipients Product
Table 102. BASF Recent Developments/Updates
Table 103. Evonik Industries Corporation Information
Table 104. Evonik Industries Description and Business Overview
Table 105. Evonik Industries Specialty Biopharmaceutical Excipients Sales (Tons), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 106. Evonik Industries Specialty Biopharmaceutical Excipients Product
Table 107. Evonik Industries Recent Developments/Updates
Table 108. J. RETTENMAIER & SOHNE GmbH Corporation Information
Table 109. J. RETTENMAIER & SOHNE GmbH Description and Business Overview
Table 110. J. RETTENMAIER & SOHNE GmbH Specialty Biopharmaceutical Excipients Sales (Tons), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 111. J. RETTENMAIER & SOHNE GmbH Specialty Biopharmaceutical Excipients Product
Table 112. J. RETTENMAIER & SOHNE GmbH Recent Developments/Updates
Table 113. Production Base and Market Concentration Rate of Raw Material
Table 114. Key Suppliers of Raw Materials
Table 115. Specialty Biopharmaceutical Excipients Distributors List
Table 116. Specialty Biopharmaceutical Excipients Customers List
Table 117. Specialty Biopharmaceutical Excipients Market Trends
Table 118. Specialty Biopharmaceutical Excipients Growth Drivers
Table 119. Specialty Biopharmaceutical Excipients Market Challenges
Table 120. Specialty Biopharmaceutical Excipients Market Restraints
Table 121. Global Specialty Biopharmaceutical Excipients Sales Forecast by Type (2022-2027) & (Tons)
Table 122. Global Specialty Biopharmaceutical Excipients Sales Market Share Forecast by Type (2022-2027)
Table 123. Global Specialty Biopharmaceutical Excipients Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 124. Global Specialty Biopharmaceutical Excipients Revenue Market Share Forecast by Type (2022-2027)
Table 125. Global Specialty Biopharmaceutical Excipients Sales Forecast by Application (2022-2027) & (Tons)
Table 126. Global Specialty Biopharmaceutical Excipients Sales Market Share Forecast by Application (2022-2027)
Table 127. Global Specialty Biopharmaceutical Excipients Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 128. Global Specialty Biopharmaceutical Excipients Revenue Market Share Forecast by Application (2022-2027)
Table 129. Global Specialty Biopharmaceutical Excipients Sales Forecast by Region (2022-2027) & (Tons)
Table 130. Global Specialty Biopharmaceutical Excipients Sales Market Share Forecast by Region (2022-2027)
Table 131. Global Specialty Biopharmaceutical Excipients Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 132. Global Specialty Biopharmaceutical Excipients Revenue Market Share Forecast by Region (2022-2027)
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Specialty Biopharmaceutical Excipients
Figure 2. Global Specialty Biopharmaceutical Excipients Market Share by Type in 2020 & 2027
Figure 3. 膨胀剂 Product Picture
Figure 4. 溶解度增强剂 Product Picture
Figure 5. 表面活性剂 Product Picture
Figure 6. 其他 Product Picture
Figure 7. Global Specialty Biopharmaceutical Excipients Market Share by Application in 2020 & 2027
Figure 8. Oral Medication
Figure 9. Injection Medicine
Figure 10. Other
Figure 11. Global Specialty Biopharmaceutical Excipients Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Specialty Biopharmaceutical Excipients Market Size 2016-2027 (US$ Million)
Figure 13. Global Specialty Biopharmaceutical Excipients Sales 2016-2027 (Tons)
Figure 14. Global Specialty Biopharmaceutical Excipients Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 15. Specialty Biopharmaceutical Excipients Sales Share by Manufacturers in 2020
Figure 16. Global Specialty Biopharmaceutical Excipients Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Specialty Biopharmaceutical Excipients Players: Market Share by Revenue in 2020
Figure 18. Specialty Biopharmaceutical Excipients Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Specialty Biopharmaceutical Excipients Sales Market Share by Region (2016-2021)
Figure 20. Global Specialty Biopharmaceutical Excipients Sales Market Share by Region in 2020
Figure 21. Global Specialty Biopharmaceutical Excipients Revenue Market Share by Region (2016-2021)
Figure 22. Global Specialty Biopharmaceutical Excipients Revenue Market Share by Region in 2020
Figure 23. United States Specialty Biopharmaceutical Excipients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Specialty Biopharmaceutical Excipients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Specialty Biopharmaceutical Excipients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Specialty Biopharmaceutical Excipients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Specialty Biopharmaceutical Excipients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Specialty Biopharmaceutical Excipients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Specialty Biopharmaceutical Excipients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Specialty Biopharmaceutical Excipients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Specialty Biopharmaceutical Excipients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Specialty Biopharmaceutical Excipients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Specialty Biopharmaceutical Excipients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Specialty Biopharmaceutical Excipients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Taiwan Specialty Biopharmaceutical Excipients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Specialty Biopharmaceutical Excipients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Specialty Biopharmaceutical Excipients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Specialty Biopharmaceutical Excipients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Specialty Biopharmaceutical Excipients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Specialty Biopharmaceutical Excipients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Specialty Biopharmaceutical Excipients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Colombia Specialty Biopharmaceutical Excipients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Specialty Biopharmaceutical Excipients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Specialty Biopharmaceutical Excipients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. UAE Specialty Biopharmaceutical Excipients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Specialty Biopharmaceutical Excipients by Type (2016-2021)
Figure 47. Sales Market Share of Specialty Biopharmaceutical Excipients by Application (2016-2021)
Figure 48. Sales Market Share of Specialty Biopharmaceutical Excipients by Application in 2020
Figure 49. Revenue Share of Specialty Biopharmaceutical Excipients by Application (2016-2021)
Figure 50. Revenue Share of Specialty Biopharmaceutical Excipients by Application in 2020
Figure 51. Manufacturing Cost Structure of Specialty Biopharmaceutical Excipients
Figure 52. Manufacturing Process Analysis of Specialty Biopharmaceutical Excipients
Figure 53. Specialty Biopharmaceutical Excipients Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed